Target intelligence / Profile preview

Transcription elongation factor A protein-like 1 (TCEAL1)

Target
TCEAL1
Molecular classification
Transcription factor, Nuclear phosphoprotein, Transcription elongation factor A (SII)-like protein family
01

Overview

Transcription elongation factor A protein-like 1 (TCEAL1) is a nuclear phosphoprotein belonging to the transcription elongation factor A (SII)-like (TCEAL) gene family, encoded on the human X chromosome at Xq22.2[1][3]. It modulates transcription in a promoter context-dependent manner, likely through protein-protein interactions with other transcriptional regulators rather than direct DNA binding[1][3]. The protein contains a zinc finger-like motif and a sequence related to the Pol II-binding region of transcription factor SII[1][3]. Variants in TCEAL1 have recently been implicated in neurodevelopmental disorders characterized by developmental delay, intellectual disability, autism spectrum disorder-like behaviors, hypotonia, gait abnormalities, and mild craniofacial dysmorphism[2][7]. The full disease spectrum is still being defined, but TCEAL1 appears to be essential for proper transcriptional regulation in neurons and other cell types[1][2][7].

Other names
TCEAL1SIIRTCEA-like protein 1p21pp21WEX9nuclear phosphoprotein p21/SIIRtranscription elongation factor S-II protein-like 1HIJRSNEDGFAX
02

Biological functions

Regulation of transcription elongationModulation of promoter activity in a context-dependent mannerProtein-protein interactions with transcriptional regulators
03

Disease associations

Neurodevelopmental disorders (including intellectual disability, developmental delay, autism spectrum behaviors)Syndromic diseases with facial and neurological features (e.g., Hijazi-Reis syndrome)

Beyond the preview

Go deeper on Transcription elongation factor A protein-like 1 (TCEAL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription elongation factor A protein-like 1 (TCEAL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call